Princeton Capital Management LLC Dexcom Inc Transaction History

Princeton Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $399,441 - $780,728	5,875 Added 298.37%	7,844 $585,000
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $3,198 - $4,426	-34 Reduced 1.7%	1,969 $1.01 Million
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $33,506 - $42,007	258 Added 14.79%	2,003 $1.08 Million
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $40,122 - $53,835	376 Added 27.47%	1,745 $954,000
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $27,941 - $37,235	345 Added 33.69%	1,369 $585,000
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $86,824 - $107,253	1,024 New	1,024 $368,000

1,019

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.